Cheng Cheng Selected Research

Remission Induction

1/2020	Reduced-dose intensity therapy for pediatric lymphoblastic leukemia: long-term results of the Recife RELLA05 pilot study.
5/2019	Ecological principle meets cancer treatment: treating children with acute myeloid leukemia with low-dose chemotherapy.
1/2019	Treatment abandonment in childhood acute lymphoblastic leukaemia in China: a retrospective cohort study of the Chinese Children's Cancer Group.
1/2019	Treatment response and outcome of children with T-cell acute lymphoblastic leukemia expressing the gamma-delta T-cell receptor.
4/2015	Clinical utility of sequential minimal residual disease measurements in the context of risk-based therapy in childhood acute lymphoblastic leukaemia: a prospective study.
9/2014	Outcomes of children with BCR-ABL1–like acute lymphoblastic leukemia treated with risk-directed therapy based on the levels of minimal residual disease.
11/2012	Genome-wide association study identifies germline polymorphisms associated with relapse of childhood acute lymphoblastic leukemia.
2/2011	Improved prognosis for older adolescents with acute lymphoblastic leukemia.
6/2009	Treating childhood acute lymphoblastic leukemia without cranial irradiation.
1/2009	Genome-wide interrogation of germline genetic variation associated with treatment response in childhood acute lymphoblastic leukemia.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Cheng Cheng Research Topics

Disease

81	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 11/2022 - 03/2002
80	Neoplasms (Cancer) 06/2022 - 03/2003
36	Leukemia 01/2022 - 05/2003
24	Inflammation (Inflammations) 12/2021 - 12/2009
17	Residual Neoplasm 01/2021 - 08/2006
14	Infections 07/2019 - 12/2004
11	Carcinogenesis 01/2022 - 12/2015
11	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2016
11	Osteonecrosis (Kienbock's Disease) 12/2021 - 06/2009
9	Type 2 Diabetes Mellitus (MODY) 01/2022 - 01/2019
9	Neuroblastoma 01/2022 - 01/2016
7	Hearing Loss (Hearing Impairment) 04/2022 - 01/2014
7	Parkinson Disease (Parkinson's Disease) 01/2022 - 01/2018
7	Osteosarcoma (Osteogenic Sarcoma) 12/2021 - 01/2019
7	Alzheimer Disease (Alzheimer's Disease) 09/2021 - 01/2016
7	Hypertension (High Blood Pressure) 01/2021 - 06/2008
6	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 06/2015
6	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021 - 01/2016
6	Hepatocellular Carcinoma (Hepatoma) 01/2021 - 12/2015
6	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 11/2016
6	Thrombosis (Thrombus) 01/2020 - 08/2003
5	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 04/2022 - 05/2019
5	Heart Arrest (Cardiac Arrest) 01/2022 - 01/2021
5	Fibrosis (Cirrhosis) 01/2022 - 03/2014
5	Pain (Aches) 01/2022 - 12/2011
5	Body Weight (Weight, Body) 09/2021 - 04/2010
5	Neuroinflammatory Diseases 09/2021 - 01/2017
5	Prostatic Neoplasms (Prostate Cancer) 05/2019 - 07/2015
4	Chronic Obstructive Pulmonary Disease (COPD) 01/2022 - 01/2019
4	Ventricular Fibrillation 01/2022 - 01/2021
4	Lung Neoplasms (Lung Cancer) 12/2021 - 01/2020
4	Colitis 12/2021 - 09/2019
4	Hypoxia (Hypoxemia) 11/2021 - 01/2017
4	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 01/2021 - 02/2009
4	Osteoporosis 01/2020 - 06/2008
4	Philadelphia Chromosome 01/2020 - 05/2014
4	Asthma (Bronchial Asthma) 01/2019 - 01/2018
3	Glioblastoma (Glioblastoma Multiforme) 06/2022 - 01/2020
3	Ototoxicity 04/2022 - 01/2014
3	Sensorineural Hearing Loss 01/2022 - 01/2019
3	Emphysema 01/2022 - 09/2021
3	COVID-19 01/2022 - 01/2021
3	Pathologic Processes 12/2021 - 05/2020
3	Carcinoma (Carcinomatosis) 12/2021 - 09/2016
3	Atherosclerosis 11/2021 - 01/2021

Drug/Important Bio-Agent (IBA)

24	Pharmaceutical PreparationsIBA 04/2022 - 05/2003
22	Proteins (Proteins, Gene)FDA Link 12/2021 - 09/2011
17	Biomarkers (Surrogate Marker)IBA 01/2022 - 04/2008
13	GlucocorticoidsIBA 01/2021 - 06/2008
13	Methotrexate (Mexate)FDA LinkGeneric 12/2020 - 05/2003
12	Biological ProductsIBA 01/2022 - 08/2007
12	MicroRNAs (MicroRNA)IBA 01/2022 - 06/2016
11	Asparaginase (Elspar)FDA Link 01/2022 - 08/2004
10	CytokinesIBA 01/2022 - 03/2016
9	Dexamethasone (Maxidex)FDA LinkGeneric 01/2021 - 11/2004
7	Circular RNAIBA 12/2021 - 01/2019
7	VaccinesIBA 01/2021 - 02/2007
6	AminoglycosidesIBA 04/2022 - 01/2014
6	Neomycin FDA LinkGeneric 04/2022 - 01/2014
6	LipidsIBA 01/2022 - 02/2011
6	Messenger RNA (mRNA)IBA 03/2021 - 08/2006
6	Transcription Factors (Transcription Factor)IBA 01/2021 - 09/2014
6	Vincristine (Oncovin)FDA LinkGeneric 01/2021 - 08/2004
6	Therapeutic UsesIBA 01/2020 - 02/2005
6	AntibodiesIBA 10/2019 - 01/2010
5	Reactive Oxygen Species (Oxygen Radicals)IBA 04/2022 - 01/2016
5	Mercaptopurine (6 Mercaptopurine)FDA LinkGeneric 01/2022 - 05/2003
5	Amyloid (Amyloid Fibrils)IBA 09/2021 - 01/2016
5	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 01/2010
5	Triglycerides (Triacylglycerol)IBA 01/2020 - 01/2017
5	InterleukinsIBA 01/2020 - 03/2016
4	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 01/2018
4	Insulin (Novolin)FDA Link 01/2022 - 01/2015
4	SteroidsIBA 12/2021 - 05/2007
4	RNA (Ribonucleic Acid)IBA 12/2021 - 04/2015
4	Competitive Endogenous RNAIBA 12/2021 - 01/2019
4	Long Noncoding RNAIBA 09/2021 - 01/2019
4	Indicators and Reagents (Reagents)IBA 08/2021 - 08/2006
4	InflammasomesIBA 01/2021 - 06/2015
4	AntigensIBA 01/2021 - 03/2015
4	Polysaccharides (Glycans)IBA 01/2021 - 01/2014
4	Phosphotransferases (Kinase)IBA 01/2021 - 09/2014
4	HDL CholesterolIBA 12/2020 - 07/2015
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020 - 01/2017
4	Tyrosine Kinase InhibitorsIBA 01/2020 - 05/2014
4	Prednisolone (Predate)FDA LinkGeneric 01/2020 - 08/2004
4	Peptides (Polypeptides)IBA 01/2019 - 09/2017
3	venetoclaxIBA 04/2022 - 01/2020
3	N-methyladenosineIBA 01/2022 - 03/2021
3	6-methyladenineIBA 01/2022 - 03/2021
3	salicylhydroxamic acid (SHAM)IBA 01/2022 - 01/2021
3	SmokeIBA 01/2022 - 12/2020

Therapy/Procedure

79	Therapeutics 03/2022 - 03/2002
27	Drug Therapy (Chemotherapy) 01/2022 - 08/2004
14	Remission Induction 01/2020 - 11/2004
5	Immunotherapy 12/2021 - 01/2020
5	Cranial Irradiation 01/2021 - 11/2004
4	Cardiopulmonary Resuscitation (CPR) 01/2022 - 01/2021
4	Cell Transplantation 12/2021 - 01/2019
3	Resuscitation 01/2022 - 01/2021